$AX

CEO at Axos Financial (NYSE: AX) receives 61,482 RSUs

Axos Financial (AX) granted its CEO, Gregory Garrabrants, 61,482 restricted stock units (RSUs) on September 3, 2026, as part of his employment contract. The RSUs vest over four years, with 25% vesting each year. Garrabrants now holds 454,229 RSUs directly. Each RSU represents a contingent right to receive one share of AX common stock.

Original reporting
Published Sep 4, 2026, 7:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 5, 2026, 1:41 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$AX
Neutral
high confidence
Mentioned
$AX
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$AXNeutralLow
01

Why it matters

The RSU award adds to insider holdings but does not involve an immediate cash transaction; market reaction is expected to be muted.

02

Market read

A routine Form 4 RSU grant with limited material impact on the stock.

03

What to watch

Potential future dilution if RSUs vest and are sold, but timing and market impact remain uncertain.

Relevance 4/10Novelty 4/10Timing: September 3, 2026 filing date

Background

Axos Financial (NASDAQ: AX) is a US‑based bank holding company. The filing is a routine insider equity award under its 2014 stock incentive plan.

Company-level read

Ticker impact

$AXNeutralHigh confidence
Context

CEO Gregory Garrabrants received a grant of 61,482 RSUs on September 3, 2026, increasing his total RSU holdings to 454,229.

Expected impact

Minimal effect; share price likely unchanged in the short term.

Evidence & confidence

Form 4 filings are primary source disclosures, but the grant size is small relative to market cap and carries no cash flow.

Market effects

None; the RSU grant is a company‑specific insider event.

None; limited to Axos Financial investors.

None

Counterpoint

The grant could be seen as a signal of confidence from management, but the modest size limits any bullish case.

Key entities

  • Gregory Garrabrants

    President and Chief Executive Officer of Axos Financial

Related articles

$AXMed

Axos Target Rises to $120 on Growth Above Peers

Axos Financial (NYSE:AX) rose 1.67% after Benchmark raised its price target to $120 from $115 and kept a Buy rating. Benchmark cited a higher multiple, 12.8x its 2027 EPS estimate. It said Axos’s loan growth, profitability, and tangible book value accretion stand out. Axos reported Q4 diluted EPS $2.53 vs $2.16 expected, revenue $379.77M vs $376.59M.

$AXMed

Axos Financial (AX) Q4 2025 Earnings Call Transcript

Axos Financial (NYSE:AX) reported Q4 ended June 30, 2025 results on an earnings call. Net loan growth was $856 million, net interest margin 4.84%, net interest income $280 million, deposits $20.8 billion, and net income $110.7 million. Adjusted diluted EPS was $1.87. Management projected mid-to-high single digits to low teens loan growth for fiscal 2026 and cited a lower CA tax rate starting Sept 2025.

$AXMed

Axos Financial (AX) Q4 2025 Earnings Call Transcript

Axos Financial (AX) reported Q4 ended June 30, 2025 net loan growth of $856 million and net interest margin of 4.84%. Net interest income rose to $280 million and net income was $110.7 million. Deposits were $20.8 billion. Adjusted diluted EPS was $1.87. Management projected mid-to-high single digits to low teens loan growth for fiscal 2026 and cited a 26% to 27% future tax rate.

$AXMed

Axos Financial (AX) Q4 2025 Earnings Call Transcript

Thursday, July 30, 2025 at 5:00 p.m. ET CALL PARTICIPANTS SVP, corporate development and IR - Johnny Y. Lai President and Chief Executive Officer - Gregory Garrabrants Executive Vice President, and Chief Financial Officer - Derrick Walsh TAKEAWAYS Net Loan Growth -- $856 million for the quarter ended June 30, 2025, driven by originations in asset-based lending, commercial real estate specialty, and equipment leasing.

$AXMedAI 8/10

Axos Financial Q4 Results: Net Income Rises 12.9% To $124.9 Million

Axos Financial (NYSE: AX) reported Q4 FY26 net income of $124.9 million, up 12.9% from $110.7 million a year earlier. Diluted EPS rose to $2.16 from $1.92, and non-GAAP adjusted EPS increased to $2.53 from $1.94. Net interest income grew 13.5% to $317.9 million and non-interest income rose 49.9% to $61.9 million, with assets up 20.9% to $30.0 billion.

$AXMedAI 9/10

[AX Q4 2026 Earnings Call] Axos Financial EPS Soars 28% on Fees and Loan Surge; $2.4B Pipeline Signals More Growth — BigGo Finance

Axos Financial (AX) reported fiscal Q4 2026 adjusted diluted EPS of $2.46, up 28%, driven by loan growth, higher non-interest income from Verdant prepayment penalties, and expense control. Reported net income was $124.9M ($2.16/share) including a $21M legal accrual. Loans grew, deposits rose to $24.6B, and management cited a $2.4B loan pipeline and integration progress from acquisitions.